Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 1Recurrence 1Neoplasms 1Multiple Myeloma 1Lymphoma, Large B-Cell, Diffuse 1Lymphatic Metastasis 1Lung Neoplasms 1Hypoxic Tumours 1Hypoxia 1Head and Neck Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Surveys and Questionnaires 26Blood Specimen Collection 19Radiotherapy 17Gene Expression Profiling 11Immunohistochemistry 9Cetuximab 6Polymerase Chain Reaction 5Nivolumab 5Immunotherapy 5Cisplatin 5Microarray Analysis 4Drug Therapy 4Biopsy 4pembrolizumab 3Tissue Banks 3Therapeutics 3Reverse Transcriptase Polymerase Chain Reaction 3Restraint, Physical 3Radiotherapy, Intensity-Modulated 3Radiation 3Observation 3Interviews as Topic 3Immunologic Techniques 3Immunoenzyme Techniques 3Flow Cytometry 3Chemotherapy, Adjuvant 3Surgical Procedures, Operative 2Quality of Life 2Psychiatric Rehabilitation 2Physical Therapy Modalities 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Head and Neck Neoplasms × fluoroazomycin arabinoside × Clear all
NCT01017224 2012-05-14

DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC)

University of Aarhus

Completed
40 enrolled
Head & Neck

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡